Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
61
2
2
54
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
4.9%
3 terminated/withdrawn out of 61 trials
94.7%
+8.2% vs industry average
30%
18 trials in Phase 3/4
4%
2 of 54 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (61)
International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases
Role: lead
Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2
Role: lead
International Prospective Observational Cohort Study for Optimal Bowel Resection Extent and Central Radicality for Colon Cancer
Role: lead
A Registry Study on Primary/idiopathic Triglyceride Deposit Cardiomyovasculopathy
Role: lead
Homologous Recombination Inquiry Through Ovarian Malignancy Investigations
Role: lead
The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia
Role: lead
Study of Long-term HFNC for COPD Patients with HOT
Role: lead
Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer
Role: lead
Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
Role: lead
Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor
Role: lead
Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer
Role: lead
CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study）
Role: lead
A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC
Role: lead
Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide
Role: lead
Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease (PERSEUS)
Role: collaborator
Transcoronary Infusion of Cardiac Progenitor Cells in Pediatric Dilated Cardiomyopathy
Role: collaborator
Eribulin Treatment as 1st-line or 2nd-line Chemotherapy for HER2-negative Hormone-resistant Inoperable or Recurrent Metastatic Breast Cancer
Role: lead
Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study
Role: lead
Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents
Role: lead
Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal Cancer
Role: lead